Sales and Marketing

Showing 15 posts of 11527 posts found.

Success for Amgen’s ‘bad’ cholesterol injection

March 18, 2014 Research and Development, Sales and Marketing Amgen, LDL, PCSK9, evolocumab, hofh, tesla

An investigational PCSK9 Inhibitor from Amgen has reduced LDL-C (‘bad’ cholesterol) in patients suffering from a rare genetic disorder in …

BMS hopes for Yervoy sequel with new deal

March 18, 2014 Research and Development, Sales and Marketing Avapro, BMS, Plavix, Yervoy, five prime, immune-oncology

Bristol-Myers Squibb has announced a new research and development deal with Five Prime Therapeutics aimed at discovering potentially new cancer …

Pfizer sues over Viagra generic

March 18, 2014 Sales and Marketing ED, FDA, Pfizer, Sildenafil, torrent, viagra

Pfizer is suing Torrent Pharmaceuticals in order to stop it selling copycat versions on its big-selling erectile-dysfunction drug Viagra. The …

Patheon completes $2.65 billion merger with DSM

March 18, 2014 Manufacturing and Production, Sales and Marketing CDMO, DSM, Patheon, dpx, manufacturing

The $2.65 billion merger between Patheon and DSM’s pharma business has completed, creating a new privately-held company called DPx.  The …

IDEA Pharma appoints vice president

March 18, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing IDEA Pharma, Jacquelyn Nicholson

Biopharma firm IDEA Pharma has appointed Jacquelyn Nicholson as vice president to head up its west coast US operations. Nicholson …

Boehringer’s first cancer drug gains NICE yes

March 17, 2014 Sales and Marketing Boehringer, Cancer, NICE, NSCLC, afatinib, giotrif

NICE is recommending that Boehringer Ingelheim’s first oncology treatment Giotrif be funded by the NHS. The new final draft guidance …

Amgen melanoma vaccine shrinks tumours

March 17, 2014 Research and Development, Sales and Marketing Amgen, Cancer, Yervoy, melanoma, t-vec

Amgen’s investigational cancer vaccine T-vec has managed to shrink the size of advanced melanoma tumours in a late-stage trial. The …

Major new launches for 2014

March 17, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AZ, AbbVie, Big Pharma, Merck, Novartis, Pfizer, Roche, Sanofi, ask, johnson, lilly, top 10

 AbbVie AbbVie needs a blockbuster to eventually replace its flagship Humira – and is hoping its new hepatitis C treatments …

IMS Health appoints general manager

March 17, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing IMS Health, sheppard

Technology services firm IMS Health has named Tim Sheppard as the new general manager for its UK and Ireland business.  Sheppard …

EFPIA targets MEPs in social media campaign

March 17, 2014 Medical Communications, Sales and Marketing EFPIA, EU, bergstrom, pharma summit, social media

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has launched a social media campaign aimed at MEPs. With ten …

NHS unions threaten action

March 14, 2014 Sales and Marketing Hunt, NHS, UK, nhsprb, nurses

Unions representing NHS staff in England have reacted strongly to a new round of below-inflation pay rises and have threatened …

New director named at Celgene

March 14, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, moore

Biopharma firm Celgene has appointed Rob Moore as its new Inflammation and Immunology business unit director. Moore has worked in …

BIA ‘disappointed’ by early access funding

March 14, 2014 Research and Development, Sales and Marketing BIA, NHS, bates, dams, early access

The BioIndustry Association (BIA) is ‘disappointed’ that the government is not funding the much-anticipated Early Access to Medicines Scheme (EAMS). …

Pharma must use cloud-based tech, says report

March 13, 2014 Medical Communications, Sales and Marketing IMS, cloud, digital, pharma, technology

Cloud-based technologies are the way forward for the pharma sector as global budget pressures continue to bite – that is …

Roche test for HPV recommended by FDA committee

March 13, 2014 Sales and Marketing Cancer, FDA, HPV, Roche, cervical, cobas

An FDA advisory committee has recommended that a DNA test developed by Roche be approved for use as a primary …
The Gateway to Local Adoption Series

Latest content